# To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)

> **NCT05732766** · PHASE3 · UNKNOWN · sponsor: **Bharat Biotech International Limited** · enrollment: 1800 (estimated)

## Conditions studied

- Cholera

## Interventions

- **BIOLOGICAL:** Hillchol vaccine

## Key facts

- **NCT ID:** NCT05732766
- **Lead sponsor:** Bharat Biotech International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-04
- **Primary completion:** 2023-03
- **Final completion:** 2023-08
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2023-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05732766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05732766, "To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05732766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*